Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD)

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD). / Joffe, P; Olsen, F; Heaf, J G; Gammelgaard, Bente; Pödenphant, J.

I: Clinical Nephrology, Bind 32, Nr. 3, 1989, s. 133-8.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Joffe, P, Olsen, F, Heaf, JG, Gammelgaard, B & Pödenphant, J 1989, 'Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD)', Clinical Nephrology, bind 32, nr. 3, s. 133-8.

APA

Joffe, P., Olsen, F., Heaf, J. G., Gammelgaard, B., & Pödenphant, J. (1989). Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Clinical Nephrology, 32(3), 133-8.

Vancouver

Joffe P, Olsen F, Heaf JG, Gammelgaard B, Pödenphant J. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Clinical Nephrology. 1989;32(3):133-8.

Author

Joffe, P ; Olsen, F ; Heaf, J G ; Gammelgaard, Bente ; Pödenphant, J. / Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD). I: Clinical Nephrology. 1989 ; Bind 32, Nr. 3. s. 133-8.

Bibtex

@article{8c1604bf4452444dadeb6c7bd7e6d125,
title = "Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD)",
abstract = "Aluminum (Al) concentration in serum, urine, and dialysate was estimated in 21 patients undergoing continuous ambulatory peritoneal dialysis (CAPD). In 12 of the patients bone Al concentration was measured as well. Mean serum Al level was 32.4 +/- 21.0 micrograms/l. The Al concentrations in the dialysate and urine were 9.1 +/- 4.1 micrograms/l and 52.5 +/- 47.3 micrograms/l, respectively. Bone Al concentration was 21.0 +/- 14.9 ppm and correlated significantly with concentrations of Al in serum (p less than 0.01) and dialysate (p less than 0.01). A mass transfer (MT) from the patients to the dialysate was observed in all patients (-44.0 +/- 28.8 micrograms/24 h). There was a highly significant correlation between peritoneal Al MT and serum Al (p less than 0.001), actual Al consumption (p less than 0.05) and bone Al concentration (p less than 0.005) supporting the existence of an overflow phenomenon. Despite very low Al levels in the dialysate, patients are at risk of elevated Al levels in the serum, dialysate, urine and bone because of consumption of Al-containing phosphate binders.",
keywords = "Adult, Aged, Aged, 80 and over, Aluminum, Bone and Bones, Dialysis Solutions, Female, Humans, Kidney Failure, Chronic, Male, Middle Aged, Peritoneal Dialysis, Continuous Ambulatory, Regression Analysis",
author = "P Joffe and F Olsen and Heaf, {J G} and Bente Gammelgaard and J P{\"o}denphant",
year = "1989",
language = "English",
volume = "32",
pages = "133--8",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "3",

}

RIS

TY - JOUR

T1 - Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD)

AU - Joffe, P

AU - Olsen, F

AU - Heaf, J G

AU - Gammelgaard, Bente

AU - Pödenphant, J

PY - 1989

Y1 - 1989

N2 - Aluminum (Al) concentration in serum, urine, and dialysate was estimated in 21 patients undergoing continuous ambulatory peritoneal dialysis (CAPD). In 12 of the patients bone Al concentration was measured as well. Mean serum Al level was 32.4 +/- 21.0 micrograms/l. The Al concentrations in the dialysate and urine were 9.1 +/- 4.1 micrograms/l and 52.5 +/- 47.3 micrograms/l, respectively. Bone Al concentration was 21.0 +/- 14.9 ppm and correlated significantly with concentrations of Al in serum (p less than 0.01) and dialysate (p less than 0.01). A mass transfer (MT) from the patients to the dialysate was observed in all patients (-44.0 +/- 28.8 micrograms/24 h). There was a highly significant correlation between peritoneal Al MT and serum Al (p less than 0.001), actual Al consumption (p less than 0.05) and bone Al concentration (p less than 0.005) supporting the existence of an overflow phenomenon. Despite very low Al levels in the dialysate, patients are at risk of elevated Al levels in the serum, dialysate, urine and bone because of consumption of Al-containing phosphate binders.

AB - Aluminum (Al) concentration in serum, urine, and dialysate was estimated in 21 patients undergoing continuous ambulatory peritoneal dialysis (CAPD). In 12 of the patients bone Al concentration was measured as well. Mean serum Al level was 32.4 +/- 21.0 micrograms/l. The Al concentrations in the dialysate and urine were 9.1 +/- 4.1 micrograms/l and 52.5 +/- 47.3 micrograms/l, respectively. Bone Al concentration was 21.0 +/- 14.9 ppm and correlated significantly with concentrations of Al in serum (p less than 0.01) and dialysate (p less than 0.01). A mass transfer (MT) from the patients to the dialysate was observed in all patients (-44.0 +/- 28.8 micrograms/24 h). There was a highly significant correlation between peritoneal Al MT and serum Al (p less than 0.001), actual Al consumption (p less than 0.05) and bone Al concentration (p less than 0.005) supporting the existence of an overflow phenomenon. Despite very low Al levels in the dialysate, patients are at risk of elevated Al levels in the serum, dialysate, urine and bone because of consumption of Al-containing phosphate binders.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Aluminum

KW - Bone and Bones

KW - Dialysis Solutions

KW - Female

KW - Humans

KW - Kidney Failure, Chronic

KW - Male

KW - Middle Aged

KW - Peritoneal Dialysis, Continuous Ambulatory

KW - Regression Analysis

M3 - Journal article

C2 - 2791364

VL - 32

SP - 133

EP - 138

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 3

ER -

ID: 44053244